Tielen, R., Verhoef, C., van Coevorden, F., Gelderblom, H., Sleijfer, S., Hartgrink, H. H., . . . de Wilt, J. H. W. (2012). Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: Is it worthwhile? BioMed Central.
Citação norma ChicagoTielen, Ronald, Cornelis Verhoef, Frits van Coevorden, Hans Gelderblom, Stefan Sleijfer, Henk H. Hartgrink, Johannes J. Bonenkamp, Winette T. van der Graaf, and Johannes H W. de Wilt. Surgery After Treatment With Imatinib And/or Sunitinib in Patients With Metastasized Gastrointestinal Stromal Tumors: Is It Worthwhile? BioMed Central, 2012.
Deismireacht MLATielen, Ronald, et al. Surgery After Treatment With Imatinib And/or Sunitinib in Patients With Metastasized Gastrointestinal Stromal Tumors: Is It Worthwhile? BioMed Central, 2012.